The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hammond Janet Mj since 2024.
This trader's CIK number is 1829899.
At the time of last reporting, Hammond Janet Mj was the Chief Development Officer of Atea Pharmaceuticals, Inc.. (stock ticker symbol AVIR).
Also see all insider trading activities at Atea Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | AVIR | 0 | $0 | 0 | $0 | 46,800 | $0 |
| 2024 | AVIR | 0 | $0 | 14,029 | $53,913 | 46,800 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-31 | AVIR | Option Ex | 46,800 | .00 | 0 |
| 2024-02-01 | AVIR | Sale | 14,029 | 3.84 | 53,913 |
| 2024-01-31 | AVIR | Option Ex | 46,800 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hammond Janet Mj (Chief Development Officer of Atea Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.